CD300E (CD300e molecule) is a transmembrane glycoprotein that functions as an immune-activating receptor primarily expressed in myeloid cells 1. The protein associates with the DNAX-activating protein (DAP) 12 adaptor and triggers intracellular calcium mobilization and superoxide anion production in monocytes upon engagement 1. CD300E activation provides survival signals preventing monocyte and myeloid dendritic cell apoptosis, promotes pro-inflammatory cytokine production, and upregulates co-stimulatory molecules 1. The receptor plays dual roles in immune regulation: while it can enhance immune responses by improving antigen presentation and T-cell activation in some contexts, it also drives immunosuppressive functions in tumor-associated macrophages, promoting colorectal cancer progression 2. CD300E expression is induced by tumor-derived signals and creates an immunosuppressive microenvironment that impairs T-cell function 2. Conversely, CD300E+ macrophages facilitate liver regeneration by secreting NAMPT to promote hepatocyte proliferation 3. The receptor is upregulated across multiple cancer types and correlates with poor prognosis 4. CD300E expression can be modulated by lifestyle interventions, with exercise significantly downregulating its expression in breast cancer models 4, suggesting potential therapeutic relevance in cancer treatment and immune regulation.